Anti-Jumonji Domain Containing Protein 1B (JMJD1B, JmjC Domain-containing Histone Demethylation Prot

Anti-Jumonji Domain Containing Protein 1B (JMJD1B, JmjC Domain-containing Histone Demethylation Prot
Item number Size Datasheet Manual SDS Delivery time Quantity Price
J7876-42B.100 100 µl - -

3 - 19 business days*

696.00€
 
The methylation state of lysine residues in histone proteins is a major determinant of the... more
Product information "Anti-Jumonji Domain Containing Protein 1B (JMJD1B, JmjC Domain-containing Histone Demethylation Prot"
The methylation state of lysine residues in histone proteins is a major determinant of the formation of active and inactive regions of the genome and is crucial for the proper programming of the genome during development. Jumonji C (JmjC) domain-containing proteins represent the largest class of potential histone demethylase proteins. The JmjC domain of several proteins has been shown to catalyze the demethylation of mono-, di-, and trimethyl lysine residues via an oxidative reaction that requires iron and alpha-ketoglutarate. Based on homology, both humans and mice contain at least 30 such proteins, which can be divided into seven separate families. The JMJD1 (Jumonji domain-containing protein 1) family, also known as JHDM2 (JmjC domain-containing histone demethylation protein 2) family, contains four members: hairless (HR), JMJD1A/JHDM2A, JMJD1B/JHDM2B, and JMJD1C/JH- DM2C. Hairless is expressed in the skin and brain and acts as a co-repressor of the thyroid hormone receptor. Mutations in the hairless gene cause alopecia in both mice and humans. JMJD1A is expressed in meiotic and post-meiotic male germ cells, contributes to androgen receptor-mediated gene regulation, and is required for spermatogenesis. It has also been identified as a downstream target of OCT4 and STAT3 and is critical for the regulation of self-renewal in embryonic stem cells. JMJD1B is a more widely expressed family member and is frequently deleted in myeloid leukemia. JMJD1C (also known as TRIP8) is a co-factor of both the androgen and thyroid receptors and has a potential link to autism. Members of the JMJD1/JHDM2 family have been shown to demethylate mono-methyl and di-methyl histone H3 (Lys9). Applications: Suitable for use in Western Blot, Immunoprecipitation and Immunofluorescence/Immunocytochemistry. Other applications not tested. Recommended Dilutions: Western Blot: 1:1000 Incubate membrane with diluted antibody in 5% nonfat dry milk, 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking, overnight. , Immunoprecipitation: 1:50 , Immunofluorescence (IC): 1:200 , Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Keywords: Anti-C5orf7, EC=1.14.11.-, Anti-Nuclear protein 5qNCA, Anti-Lysine-specific demethylase 3B, Anti-Jumonji domain-containing protein 1B, Anti-JmjC domain-containing histone demethylation protein 2B
Supplier: United States Biological
Supplier-Nr: J7876-42B

Properties

Application: IF, IP, WB
Antibody Type: Monoclonal
Clone: 10E35(6A1-1F5)
Conjugate: No
Host: Mouse
Species reactivity: human, monkey, mouse, rat
Immunogen: Recombinant protein derived from the sequence of human JMJD1B.
Format: Serum

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-Jumonji Domain Containing Protein 1B (JMJD1B, JmjC Domain-containing Histone Demethylation Prot"
Write a review
or to review a product.
Viewed